ASCO 2019
Advertisement
Renal cell carcinoma (RCC) is the most common histologic type of urologic cancer. Worldwide, the age-standardized rate ...
Several therapeutic combinations of immune-oncology (IO) plus vascular endothelial growth factor (VEGF) regimens have ...
Immune Checkpoint Therapy plus Cytoreductive Surgery in mRCC
...
Immune Checkpoint Inhibitor Response in Patients with mRCC
...
Costs of episodes of care in metastatic renal cell carcinoma (mRCC) vary by therapy and treatment decisions have ...
Ipilimumab plus nivolumab is a first-line combination treatment option in patients with metastatic renal cell carcinoma ...
Nivolumab plus ipilimumab was proven superior to sunitinib in objective response rate and overall survival in patients ...
Ronan Flippot, MD, MSc, and colleagues conducted a multicenter, open-label, single arm phase 2 trial of atezolizumab ...
In previous clinical trials of patients with advanced renal cell carcinoma (aRCC), including CheckMate 214, patients ...
The prospective, multicenter study, PAZOREAL, is designed to examine the effectiveness, defined as primary time on ...
In the phase 3 KEYNOTE-426 trial, patients with metastatic renal cell carcinoma (mRCC) had significant improvement in ...
In patients with renal cell carcinoma (RCC) with low tumor burden or slow growing disease, active surveillance is a ...
Researchers reported updated results from cohort A in the KEYNOTE-427 trial during a poster session at the ASCO 2019 ...
Renal function in a large, clinically assessed cohort of childhood cancer survivors was analyzed using data from the St. ...
Treatment for advanced renal cell carcinoma (aRCC) commonly includes immune-oncology therapies and tyrosine kinase ...
There are few data available on gender-related clinical outcomes and safety of treatment of with immune check point ...
Patients with renal cell carcinoma (RCC) or urothelial carcinoma (UC) with clinically significant autoimmune disorders ...
Addition of Apalutamide to ADT Improves Survival in Castration-Resistant Prostate Cancer
...
In previously reported data from the randomized, placebo-controlled, phase III SPARTAN study, researchers found that the ...
The standard of care for smoldering multiple myeloma (SMM), a precursor to MM, is observation. However, a 2015 study ...
Advertisement
630 Madison Ave.
Manalapan, NJ 07726
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.